Sp899
SHOULD ELECTRONIC AND DYE-BASED CHROMOSCOPY REPLACE WHITE-LIGHT COLONOSCOPY AND RANDOM BIOPSIES FOR DYSPLASIA DETECTION IN PATIENTS WITH IBD: NO
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format. This 90-minute symposium will feature 3 debates among "heavyweight" faculty who will provide greater clarity as to how we can apply best evidence to clinical decision-making for these challenging topics. Debates focus on recently published AGA Clinical Practice Updates, which are evidence-based reviews and commentaries that address evolving areas of clinical practice and/or technology. These documents address topics of very high clinical importance, and are published in AGA's flagship journals Gastroenterology and CGH.
This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format. This 90-minute symposium will feature 3 debates among "heavyweight" faculty who will provide greater clarity as to how we can apply best evidence to clinical decision-making for these challenging topics. Debates focus on recently published AGA Clinical Practice Updates, which are evidence-based reviews and commentaries that address evolving areas of clinical practice and/or technology. These documents address topics of very high clinical importance, and are published in AGA's flagship journals Gastroenterology and CGH.
Presenter
Beth Israel Deaconess Medical Center
Tracks
Related Products
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
AUDIENCE POLLING AND Q&A
This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format…
